Anika Therapeutics, Inc. (ANIK) NASDAQ

14.06

+1.27(+9.93%)

Updated at February 27 11:12AM

Currency In USD

Valuation

Market Cap137.8M
Enterprise Value104.51M
P/E Ratio-21.5
PEG Ratio-0.3
Price/Sales Ratio1.8
Price/Book Ratio1.4
Enterprise/Revenue1.51
Enterprise/EBITDA-30.17

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.08
Operating Margin-0.1

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.06

Income Statement

Revenue112.82M
Revenue/Share7.9
Gross Profit63.81M
EBITDA-1.83M
Net Income-10.88M
Diluted EPS-0.76

Balance Sheet

Total Cash57.48M
Total Cash/Share4.03
Total Debt24.2M
Total Debt/Equity0.17
Current Ratio4.72
Book Value Per Share10.05

Price History

52-Week Change-20.12
52-Week High17.74
52-Week Low7.87
Moving Average 50 Days9.85
Moving Average 200 Days9.94

Statistics

Average Volume152,255
Shares Outstanding14.42M
% Held by Institutions84.78

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A